Delivery Order SPE2DR25D2106-SPE2DR26F1FNS
- Not listed
- The Defense Logistics Agency awarded a $41,652.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injector pens, with an ultimate completion date of September 29, 2025. This competitive award carries no set-aside designation and represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed and delivered from the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $8,598.16 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injector pens on October 30, 2025, with completion targeted for October 31, 2025. This firm fixed-price delivery order, executed without a set-aside designation, represents a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $14,002.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injector pens, with an ultimate completion date of August 8, 2025. This non-set-aside award was issued on August 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical supply vendor that serves military...
- The Defense Logistics Agency awarded a delivery order valued at $10,226.52 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injector pens. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by July 21, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and pharmaceutical distribution...
- The Defense Logistics Agency awarded a $16,264.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injector pens on October 16, 2025, with an ultimate completion date of October 17, 2025. This non-competitive delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract was performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $9,253.56 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injector pens, with an ultimate completion date of October 28, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger indefinite delivery contract with DLA...
- The Defense Logistics Agency awarded a $5,977.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injector pens, with an ultimate completion date of August 1, 2025. The award, issued on July 31, 2025, represents a non-set-aside, competitively awarded contract with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under the company's Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $11,857.96 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injector pens, with performance completed in Conshohocken, Pennsylvania. The contract, awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, utilized firm fixed-price pricing under a non-competitive set-aside arrangement. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $37,508.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injector pens. This competitively awarded contract, which carries no set-aside designation, was finalized on July 24, 2025, with an ultimate completion date of July 25, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Enbrel is a biologic immunosuppressant commonly prescribed for rheumatoid...
- The Defense Logistics Agency awarded a $32,259.65 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injector pens, with an ultimate completion date of July 29, 2025. This non-set-aside contract represents a competitive award to support federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems,...
- SPE2DR25D2106Indefinite Delivery Contract
- SPE2DR25D2106-SPE2DR26F1FNSDelivery Order
The Defense Logistics Agency awarded a $27,213.53 firm fixed price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injector pens, with an ultimate completion date of November 5, 2025. This non-competitive delivery order was issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The delivery will be fulfilled at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a routine execution of AmerisourceBergen's comprehensive pharmaceutical prime vendor agreement with DLA, which enables the distributor to supply a broad range of medications, biologics, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's position as a major federal pharmaceutical vendor reflects its capability to meet stringent federal procurement requirements and deliver specialized medications like Enbrel, a biologic used in the treatment of rheumatoid arthritis and other inflammatory conditions, directly to defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.2k | 11/4/25 |